S&P 500   4,587.25 (+0.78%)
DOW   35,673.23 (+0.51%)
QQQ   383.57 (+0.94%)
AAPL   152.61 (+2.53%)
MSFT   323.52 (+0.11%)
FB   315.85 (+1.16%)
GOOGL   2,917.85 (-0.22%)
TSLA   1,071.46 (+3.24%)
AMZN   3,476.18 (+2.47%)
NVDA   247.71 (+1.31%)
BABA   169.97 (+0.44%)
NIO   40.46 (+2.93%)
CGC   13.01 (+1.80%)
GE   104.28 (+0.41%)
AMD   121.09 (-0.97%)
MU   69.45 (+1.77%)
T   25.62 (+2.23%)
F   16.86 (+8.70%)
ACB   6.93 (+1.32%)
DIS   170.24 (+0.41%)
PFE   43.15 (+0.42%)
BA   207.69 (+0.52%)
AMC   35.00 (+0.69%)
S&P 500   4,587.25 (+0.78%)
DOW   35,673.23 (+0.51%)
QQQ   383.57 (+0.94%)
AAPL   152.61 (+2.53%)
MSFT   323.52 (+0.11%)
FB   315.85 (+1.16%)
GOOGL   2,917.85 (-0.22%)
TSLA   1,071.46 (+3.24%)
AMZN   3,476.18 (+2.47%)
NVDA   247.71 (+1.31%)
BABA   169.97 (+0.44%)
NIO   40.46 (+2.93%)
CGC   13.01 (+1.80%)
GE   104.28 (+0.41%)
AMD   121.09 (-0.97%)
MU   69.45 (+1.77%)
T   25.62 (+2.23%)
F   16.86 (+8.70%)
ACB   6.93 (+1.32%)
DIS   170.24 (+0.41%)
PFE   43.15 (+0.42%)
BA   207.69 (+0.52%)
AMC   35.00 (+0.69%)
S&P 500   4,587.25 (+0.78%)
DOW   35,673.23 (+0.51%)
QQQ   383.57 (+0.94%)
AAPL   152.61 (+2.53%)
MSFT   323.52 (+0.11%)
FB   315.85 (+1.16%)
GOOGL   2,917.85 (-0.22%)
TSLA   1,071.46 (+3.24%)
AMZN   3,476.18 (+2.47%)
NVDA   247.71 (+1.31%)
BABA   169.97 (+0.44%)
NIO   40.46 (+2.93%)
CGC   13.01 (+1.80%)
GE   104.28 (+0.41%)
AMD   121.09 (-0.97%)
MU   69.45 (+1.77%)
T   25.62 (+2.23%)
F   16.86 (+8.70%)
ACB   6.93 (+1.32%)
DIS   170.24 (+0.41%)
PFE   43.15 (+0.42%)
BA   207.69 (+0.52%)
AMC   35.00 (+0.69%)
S&P 500   4,587.25 (+0.78%)
DOW   35,673.23 (+0.51%)
QQQ   383.57 (+0.94%)
AAPL   152.61 (+2.53%)
MSFT   323.52 (+0.11%)
FB   315.85 (+1.16%)
GOOGL   2,917.85 (-0.22%)
TSLA   1,071.46 (+3.24%)
AMZN   3,476.18 (+2.47%)
NVDA   247.71 (+1.31%)
BABA   169.97 (+0.44%)
NIO   40.46 (+2.93%)
CGC   13.01 (+1.80%)
GE   104.28 (+0.41%)
AMD   121.09 (-0.97%)
MU   69.45 (+1.77%)
T   25.62 (+2.23%)
F   16.86 (+8.70%)
ACB   6.93 (+1.32%)
DIS   170.24 (+0.41%)
PFE   43.15 (+0.42%)
BA   207.69 (+0.52%)
AMC   35.00 (+0.69%)
NASDAQ:CTRX

Catamaran Corp USA Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
2.83 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Receive CTRX News and Ratings via Email

Sign-up to receive the latest news and ratings for Catamaran Corp USA and its competitors with MarketBeat's FREE daily newsletter.


Catamaran Corp USA logo

About Catamaran Corp USA

Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government's Medicare Part D program. The Company's HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company's customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
Health Care Services
Sector
N/A
Current Symbol
NASDAQ:CTRX
Previous Symbol
NASDAQ:SXCI
CUSIP
14888710
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Next Earnings Date
N/A
Fiscal Year End
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Catamaran Corp USA (NASDAQ:CTRX) Frequently Asked Questions

What stocks does MarketBeat like better than Catamaran Corp USA?

Wall Street analysts have given Catamaran Corp USA a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Catamaran Corp USA wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Catamaran Corp USA's earnings last quarter?

Catamaran Corp USA (NASDAQ:CTRX) issued its earnings results on Thursday, February, 26th. The healthcare company reported $0.67 EPS for the quarter, topping the consensus estimate of $0.61 by $0.06. The healthcare company earned $5.74 billion during the quarter, compared to analysts' expectations of $5.57 billion. The firm's quarterly revenue was up 26.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.56 earnings per share.
View Catamaran Corp USA's earnings history
.

What other stocks do shareholders of Catamaran Corp USA own?

What is Catamaran Corp USA's stock symbol?

Catamaran Corp USA trades on the NASDAQ under the ticker symbol "CTRX."

What is Catamaran Corp USA's official website?

The official website for Catamaran Corp USA is www.catamaranrx.com.

Where are Catamaran Corp USA's headquarters?

Catamaran Corp USA is headquartered at 1600 McConnor Pkwy, SCHAUMBURG, IL 60173-6801, United States.

How can I contact Catamaran Corp USA?

Catamaran Corp USA's mailing address is 1600 McConnor Pkwy, SCHAUMBURG, IL 60173-6801, United States. The healthcare company can be reached via phone at +1-800-2823232.


This page was last updated on 10/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.